These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30488669)

  • 41. Development of a novel, single-cycle replicable rift valley Fever vaccine.
    Murakami S; Terasaki K; Ramirez SI; Morrill JC; Makino S
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2746. PubMed ID: 24651859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Quadruple Gene-Deleted BoHV-1-Vectored RVFV Subunit Vaccine Induces Humoral and Cell-Mediated Immune Response against Rift Valley Fever in Calves.
    Pavulraj S; Stout RW; Barras ED; Paulsen DB; Chowdhury SI
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus.
    Wang Q; Ma T; Wu Y; Chen Z; Zeng H; Tong Z; Gao F; Qi J; Zhao Z; Chai Y; Yang H; Wong G; Bi Y; Wu L; Shi R; Yang M; Song J; Jiang H; An Z; Wang J; Yilma TD; Shi Y; Liu WJ; Liang M; Qin C; Gao GF; Yan J
    Nat Microbiol; 2019 Jul; 4(7):1231-1241. PubMed ID: 30936489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
    Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus.
    Pichlmair A; Habjan M; Unger H; Weber F
    Vector Borne Zoonotic Dis; 2010 Oct; 10(7):701-3. PubMed ID: 20854024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.
    Lagerqvist N; Näslund J; Lundkvist A; Bouloy M; Ahlm C; Bucht G
    Virol J; 2009 Jan; 6():6. PubMed ID: 19149901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
    Warimwe GM; Lorenzo G; Lopez-Gil E; Reyes-Sandoval A; Cottingham MG; Spencer AJ; Collins KA; Dicks MD; Milicic A; Lall A; Furze J; Turner AV; Hill AV; Brun A; Gilbert SC
    Virol J; 2013 Dec; 10():349. PubMed ID: 24304565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice.
    Morrill JC; Peters CJ; Bettinger GE; Palermo PM; Smith DR; Watts DM
    Vaccine; 2022 Nov; 40(50):7255-7261. PubMed ID: 36333222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.
    Ragan IK; Davis AS; McVey DS; Richt JA; Rowland RR; Wilson WC
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
    Indran SV; Lihoradova OA; Phoenix I; Lokugamage N; Kalveram B; Head JA; Tigabu B; Smith JK; Zhang L; Juelich TL; Gong B; Freiberg AN; Ikegami T
    J Gen Virol; 2013 Jul; 94(Pt 7):1441-1450. PubMed ID: 23515022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Equine immunoglobulin F(ab')
    Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
    Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
    Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bead-based suspension array for simultaneous detection of antibodies against the Rift Valley fever virus nucleocapsid and Gn glycoprotein.
    van der Wal FJ; Achterberg RP; de Boer SM; Boshra H; Brun A; Maassen CB; Kortekaas J
    J Virol Methods; 2012 Aug; 183(2):99-105. PubMed ID: 22449758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.
    Mandell RB; Koukuntla R; Mogler LJ; Carzoli AK; Freiberg AN; Holbrook MR; Martin BK; Staplin WR; Vahanian NN; Link CJ; Flick R
    Virology; 2010 Feb; 397(1):187-98. PubMed ID: 19932911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus.
    Moussa MI; Abdel-Wahab KS; Wood OL
    Am J Trop Med Hyg; 1986 May; 35(3):660-2. PubMed ID: 3706629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.